OS Therapies (OSTX) News Today $1.95 +0.09 (+4.83%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 15, 2024 | businesswire.comOSTX Stock Earnings: OS Therapies Reported Results for Q2 2024November 15, 2024 | investorplace.comOSTX Stock Earnings: OS Therapies Reported Results for Q2 2024November 12, 2024 | investorplace.comOSTX Stock Earnings: OS Therapies Reported Results for Q2 2024November 11, 2024 | investorplace.comOS Therapies to Present at The Spartan Capital Investor ConferenceNovember 5, 2024 | finance.yahoo.comJoin OS Therapies' Exclusive Live Investor Webinar and Q&A Session on October 30October 30, 2024 | tmcnet.comOS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of DirectorsOctober 28, 2024 | businesswire.comOS Therapies to Present at the LD Micro Main Event XVIIOctober 24, 2024 | uk.finance.yahoo.comOS Therapies (NYSE:OSTX) Stock Price Down 0.9% - Time to Sell?OS Therapies (NYSE:OSTX) Shares Down 0.9% - Here's What HappenedOctober 22, 2024 | marketbeat.comOS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitOctober 17, 2024 | finance.yahoo.comOS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient VisitOctober 3, 2024 | finance.yahoo.comOS Therapies (NYSE:OSTX) Trading Up 0.3%OS Therapies (NYSE:OSTX) Trading 0.3% HigherSeptember 27, 2024 | marketbeat.comOS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic CandidatesSeptember 13, 2024 | finance.yahoo.comOS Therapies Incorporated (OSTX)September 12, 2024 | finance.yahoo.comOS Therapies reports positive preclinical data for ovarian cancer treatmentSeptember 11, 2024 | proactiveinvestors.comOS Therapies Inc OSTXSeptember 7, 2024 | morningstar.comOS Therapies Inc (OSTX)September 6, 2024 | uk.investing.comOS Therapies (NYSE:OSTX) Stock Rating Upgraded by EF Hutton Acquisition Co. IEF Hutton Acquisition Co. I upgraded shares of OS Therapies to a "strong-buy" rating in a research report on Tuesday.September 5, 2024 | marketbeat.comOS Therapies Inc's (NYSE:OSTX) Quiet Period Will End on September 10thOS Therapies' (NYSE:OSTX - Get Free Report) quiet period is set to expire on Tuesday, September 10th. OS Therapies had issued 1,600,000 shares in its IPO on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. During OS Therapies' quiet period, insiders and any underwriters involved in the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.September 3, 2024 | marketbeat.com Get OS Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSTX and its competitors with MarketBeat's FREE daily newsletter. Email Address ⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price. Click here for the ticker >>> OSTX Media Mentions By Week OSTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OSTX News Sentiment▼-0.910.49▲Average Medical News Sentiment OSTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OSTX Articles This Week▼11▲OSTX Articles Average Week Get OS Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Checkpoint Therapeutics News Today Gossamer Bio News Today Atossa Therapeutics News Today Elutia News Today FitLife Brands News Today Bright Minds Biosciences News Today Puma Biotechnology News Today Inventiva News Today Acumen Pharmaceuticals News Today Sagimet Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:OSTX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OS Therapies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share OS Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
